{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:24:23Z","timestamp":1791300263500,"version":"4.1.0"},"reference-count":68,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the contribution of female hormonal factors occurring prior to the onset of rheumatoid arthritis (RA), such as age at menarche, parity, age at first birth, breast\u2010feeding, use of oral contraceptives (OCs), irregular menstrual cycles, and postmenopausal hormone (PMH) use, to the subsequent development of RA in a large female cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied female reproductive and hormonal risk factors for RA in a cohort of 121,700 women enrolled in the longitudinal Nurses' Health Study. The diagnosis of incident RA (between 1976 and 2002) in 674 women was confirmed by a connective tissue disease screening questionnaire and blinded medical record review for American College of Rheumatology criteria. Sixty percent of the patients with RA were rheumatoid factor positive. The relationship between potential risk factors, including age, age at menarche, parity, age at first birth, total lifetime history of breast\u2010feeding, use of OCs, and irregular menstrual cycles and the multivariate\u2010adjusted risk of RA was estimated using Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using a multivariate model that adjusted for age, body mass index, smoking, parity, and other hormonal factors, we observed a strong trend for decreasing risk of RA with increasing duration of breast\u2010feeding (\n                      <jats:italic>P<\/jats:italic>\n                      for trend = 0.001). For women who breast\u2010fed (compared with parous women who did not breast\u2010feed), the risk ratios (RRs) and 95% confidence intervals (95% CIs) were as follows: breast\u2010feeding for \u22643 total months, RR 1.0 (95% confidence interval [95% CI] 0.8\u20101.2); for 4\u201311 total months, RR 0.9 (95% CI 0.7\u20131.1); for 12\u201323 total months, RR 0.8 (95% CI 0.6\u20131.0); and for \u226524 total months, RR 0.5 (95% CI 0.3\u20130.8). Very irregular menstrual cycles were associated with an increased risk of RA (RR 1.4, 95% CI 1.0\u20132.0). Age at menarche \u226410 years was associated with an increased risk of seropositive RA (RR 1.6, 95% CI 1.1\u20132.4) but not significantly associated with risk of RA. Parity, total number of children, age at first birth, and OC use were not associated with an increased risk of RA in this cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large cohort, breast\u2010feeding for &gt;12 months was inversely related to the development of RA. This apparent effect was dose\u2010dependent, with a significant trend toward lower risk with longer duration of breast\u2010feeding. Irregular menstrual cycles and earlier age at menarche increased the risk of RA. Other reproductive hormonal factors were not associated with RA risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.20621","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T16:32:18Z","timestamp":1100277138000},"page":"3458-3467","source":"Crossref","is-referenced-by-count":293,"title":["Do breast\u2010feeding and other reproductive factors influence future risk of rheumatoid arthritis?: Results from the Nurses' Health Study"],"prefix":"10.1002","volume":"50","author":[{"given":"Elizabeth W.","family":"Karlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Grodstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112878"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.8.735"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(95)80014-X"},{"key":"e_1_2_6_5_2","first-page":"641","article-title":"Sex hormones, HLA and rheumatoid arthritis","volume":"9","author":"Cutolo M","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/27.6.440"},{"key":"e_1_2_6_7_2","first-page":"1620","article-title":"Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition","volume":"17","author":"Goemaere S","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_6_8_2","first-page":"10","article-title":"Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis","volume":"44","author":"Wilder RL","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07619.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350205"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370605"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.2.94"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oxfordjournals.aje.a117267","article-title":"An investigation of gene\u2010environment interaction in the etiology of rheumatoid arthritis","volume":"140","author":"Brennan P","year":"1994","journal-title":"Am J Epidemiol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.6.542"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(03)00084-2"},{"key":"e_1_2_6_16_2","first-page":"207","article-title":"The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study","volume":"31","author":"Doran MF","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330604"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(97)80025-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330204"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.1986.03370100093024","article-title":"Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women","volume":"255","author":"Vandenbroucke JP","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748409100377"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90809-1"},{"key":"e_1_2_6_23_2","first-page":"569","article-title":"Reduction in incidence of rheumatoid arthritis associated with oral contraceptives","volume":"1","author":"Wingrave SJ","year":"1978","journal-title":"Lancet"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.5.322"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330705"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.10.744"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.254.14.1938"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92413-3"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199007000-00005"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.509"},{"key":"e_1_2_6_31_2","first-page":"1473","article-title":"Does estrogen replacement therapy protect against rheumatoid arthritis?","volume":"18","author":"Spector TD","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_6_32_2","first-page":"911","article-title":"Postmenopausal hormones and the incidence of rheumatoid arthritis","volume":"16","author":"Carette S","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/23.6.1248"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1997.6.49"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(94)00096-C"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D"},{"key":"e_1_2_6_38_2","volume-title":"SAS\/STAT user's guide: version 6","year":"1990"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.32"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780331203"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.13"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92378-4"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.33"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1992.tb00799.x"},{"key":"e_1_2_6_45_2","first-page":"83","volume-title":"Population studies of the rheumatic diseases","author":"Engel A","year":"1968"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341205"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.8.697"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.11.811"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340102"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270612"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1991.tb00708.x"},{"key":"e_1_2_6_52_2","first-page":"839","article-title":"Prolactin: a hormone with immunoregulatory properties that leads to new therapeutic approaches in rheumatic diseases","volume":"19","author":"Lavalle C","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.150.12.5673"},{"key":"e_1_2_6_54_2","first-page":"1890","article-title":"Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis","volume":"26","author":"Nagafuchi H","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00893.x"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05415.x"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00918091"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(86)90243-6"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-4666(02)00496-9"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351107"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.5.281"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10177"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1089\/15246090152563560"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.4933"},{"key":"e_1_2_6_65_2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.122.5.1978","article-title":"Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy","volume":"122","author":"Clemens LE","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1998.4602"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(01)00035-2"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3010183"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02037-5"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.20621","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.20621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:51:40Z","timestamp":1697507500000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.20621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1002\/art.20621"],"URL":"https:\/\/doi.org\/10.1002\/art.20621","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}